Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/26/2008CN101312739A Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient
11/26/2008CN101311271A Process for producing cellulosic ethanol by recombining saccharomyces cerevisiae
11/26/2008CN101311270A Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof
11/26/2008CN101311269A Nucleotide sequence of high activity beta-galactosidase
11/26/2008CN101311268A Expression and applications of novel non-restriction endonuclease in escherichia coli
11/26/2008CN101311267A 新型植物表达构建物 The new plant expression construct
11/26/2008CN101311266A Full length cDNA homogenizing subtractive hybridization method
11/26/2008CN101311265A Hepatitis B virus complete-genome polymerase chimera and its construction process and application
11/26/2008CN101311262A Streptomyces griseus and uses thereof
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311192A Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof
11/26/2008CN101311188A Small molecule peptides inhibitor of human heparinase
11/26/2008CN101310882A Method for repairing heavy metal and organic compound contaminated soil using transgenic plant
11/26/2008CN100437105C Nucleic acid concentration quantitative analysis chip, nucleic acid concentration quantitative analysis apparatus, and nucleic acid concentration quantitative analysis method
11/26/2008CN100436594C Method for the production of S-adenosylmethionine by fermentation
11/26/2008CN100436593C Process for producing sugar nucleotides and complex carbohydrates
11/26/2008CN100436588C Blood sugar reducing method of orally taking human insulin-like growth factor-I produced in silkworm bioreactor
11/26/2008CN100436587C New multifunctional coli bacillus nonfusion protein expressing carrier and its ase
11/26/2008CN100436586C Endoglucanase NCE5 and cellulase preparations contg. same
11/26/2008CN100436585C Target gene for controlling black rot of cabbage
11/26/2008CN100436584C Seed specificity promoter, core function fragment and application thereof
11/26/2008CN100436583C Antifreeze gene from wild rice and its coded protein and application
11/26/2008CN100436582C Pathogenic bacteria infection from padly rice and injure induced gene promotor and its application
11/26/2008CN100436581C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
11/26/2008CN100436580C Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof
11/26/2008CN100436579C Vitreoscilla hemoglobin gene and its uses
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436576C Nattokinase and its coding gene and clone and expressing method
11/26/2008CN100436482C Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods
11/26/2008CN100436481C Targeted anti-tumour fused protein containing adenovirus E40rf4 protein
11/26/2008CN100436480C Platelet glycoprotein IB-alpha variant fusion polypeptides and methods of use thereof
11/26/2008CN100436478C Novel pesticidal toxins
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/26/2008CN100436470C Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof
11/26/2008CN100435851C Method and its system for leading large molecular matter into target cell
11/26/2008CN100435850C Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour
11/26/2008CN100435849C Anti-tumor agent using interleukin-23 gene
11/26/2008CN100435848C Gene treatment to raise feed efficiency and promote growth of farm animal
11/26/2008CN100435844C Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
11/25/2008US7456343 Plants and seeds of corn variety I211906
11/25/2008US7456342 Plants and seeds of corn variety I512243
11/25/2008US7456341 Soybean cultivar 4211676
11/25/2008US7456340 Canola cultivar NQC02CNX21
11/25/2008US7456339 Canola line 45H72
11/25/2008US7456338 Modification of plant lignin content
11/25/2008US7456337 Signal transduction stress-related proteins and methods of use in plants
11/25/2008US7456336 Methods for decreasing linolenic acid content in seeds from transgenic plants containing a mutant delta 15 desaturase
11/25/2008US7456335 Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
11/25/2008US7456334 Maize Cr1bio gene promoter and its use to direct root-preferred transgene expression in plants
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456276 Peptide purification by means of metal ion affinity chromatography
11/25/2008US7456274 Inhibition of metallo-β-lactamase
11/25/2008US7456273 isolated transcriptional regulatory element selected from any of SEQ ID NOS: 40; recombinant nucleic acid molecule; integrating oligonucleotide into a eukaryotic cell genome so oligonucleotide is operatively linked to an expressible polynucleotide; detecting change in expression; kit; vector
11/25/2008US7456272 Neurotoxins with enhanced target specificity
11/25/2008US7456270 Δ6-desaturase genes and uses thereof
11/25/2008US7456269 Alzheimer's disease secretase, APP substrates thereof, and uses thereof
11/25/2008US7456263 P53 binding T cell receptor molecules
11/25/2008US7456260 Humanized antibody
11/25/2008US7456257 Fusion proteins of interferon alpha muteins with improved properties
11/25/2008US7456256 Fibronectins; drug screening; treating cardiovascular/nervous system disorders
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456251 HIV fusion inhibitor peptides with improved biological properties
11/25/2008US7456197 Such as 1-(2,3-dihydroxypropyl)-2,4,6-trimethylpyridinium hexafluorophosphate; transfecting eukaryotic cells
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7456149 ALK7 and myostatin inhibitors and uses thereof
11/25/2008US7456148 Using apolipoprotein as therapeutic agent which prevents and treats thrombosis in cardiovascular and ischemia-reperfusion injuries
11/25/2008US7456020 Method for modifying chromosomes
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7456015 Nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
11/25/2008US7456014 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/25/2008US7456013 Minichromosomes for use as vectors in plant and animal transformations; artificial chromosomes; autonomous replicating sequences (ars)
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7456008 Modified virus comprising one or more non-native polypeptides
11/25/2008US7456007 β-secretase enzyme compositions and methods
11/25/2008US7456005 Modified xylanases exhibiting improved expression
11/25/2008US7456003 Isolated protein having the enzymatic activity of an amylosucrase produced by recombinant DNA
11/25/2008US7456001 A polynucleotide encoding a lipoxygenase and its use for recombinant production of a lipoxygenase; obtaining a lipoxygenase by screening a DNA library with specific probes
11/25/2008US7455999 Synthesizing polyhydroxyalkanoate in a transgenic organism having transgene encoding an enzyme selected from PHB polymerase, PHA polymerase, beta-ketothiolase, beta -ketoacyl-CoA reductase, etc., integrated into chromosome
11/25/2008US7455996 From sucrose and galactinol; biosynthesis; chromatography; electrophoresis
11/25/2008US7455994 Methods for producing Marburg virus proteins
11/25/2008US7455993 Cytokine protein family
11/25/2008US7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof
11/25/2008US7455990 Isolating hexose oxidase for use as tool in enhancement of nutrient quality of animal feeeds
11/25/2008US7455988 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
11/25/2008US7455987 Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455983 Nutrient broth for propagation of progenitor cells for use in drug screeniing and human therapy
11/25/2008US7455982 Automated methods of detecting receptor activity
11/25/2008US7455981 Method of detecting broad-spectrum delta-endotoxins
11/25/2008US7455978 Protein/solubility folding assessed by structural complementation
11/25/2008US7455977 Methods of determining the level of human TBP-II with anti-TBP-II antibody
11/25/2008US7455974 Collection of nucleic acid fragments resulting from complete digestion of one or more nucleic acids by one or more restriction endonucleases; contains at least 3 fragments; and the size of the fragments in base pairs is a multiple of an integer of 10 or more
11/25/2008US7455969 Highly permissive cell lines for hepatitis C virus RNA replication
11/25/2008US7455965 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
11/25/2008US7455964 Genes from the 20q13 amplicon and their uses
11/25/2008US7455963 Antibodies to cyclin E2 protein
11/25/2008US7455962 Obtaining cells from the aorta-gonad-mesonephros region, detecting cells comprising a podocalyxin-like protein 1-positive phenotype (e.g., using an anti-PCLP1 antibody) and isolating them, and identifying from the isolated cells those having a CD45-negative phenotype
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455842 Chimeric West Nile viruses and uses thereof